XML 79 R34.htm IDEA: XBRL DOCUMENT v3.22.0.1
Significant Accounting Policies - Summary of Percentage of Total Product Revenues (Details) - Revenue from Contract with Customer Benchmark - Customer Concentration Risk
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
OncoMed Specialty, LLC (Onco360)      
Disaggregation Of Revenue [Line Items]      
Percentage of product revenues 22.00% 0.00% 0.00%
Affiliates of McKesson Corporation      
Disaggregation Of Revenue [Line Items]      
Percentage of product revenues 42.00% 0.00% 0.00%
Affiliates of AmerisourceBergen Corporation      
Disaggregation Of Revenue [Line Items]      
Percentage of product revenues 27.00% 0.00% 0.00%